Researchers from the University of California, Santa Barbara, along with Scripps Research Institute and Sanford-Burnham Institute, have developed synthetic blood platelets that mimic natural ones. These synthetic platelets are seen as a step forward in mimicking human blood function. However, these platelets do not simply mimic natural platelets; the researchers... Read More

Piramal Healthcare, a global business conglomerate stationed in Mumbai, Indian, is acquiring Decision Resources, a US-based intellectual property and knowledge-based business, for $635 million. Piramal Healthcare specializes in contract manufacturing and generic, over-the-counter drugs, but it has recently diversified into a broad range of technology and health care markets. In... Read More

In the mid-1990s, James A. Thomson from the University of Wisconsin-Madison developed an innovative technique that led to the development of primate embryonic stem cells. On January 19, 1996 the University of Wisconsin’s Wisconsin Alumni Research Foundation (WARF) filed this patent for Primate Embryonic Stem Cells, patent number 05843780. On... Read More

In 2009, President Barack Obama lifted former President George Bush’s ban on federal funding for embryonic stem cell research utilizing new sources of embryonic cells. Unfortunately, since President Obama lifted the ban, the federal government has been embroiled in an exhaustive court battle over the fate of embryonic stem cell... Read More

In 2009, Barack Obama issued Executive Order 13505, which allowed the National Institutes of Health (NIH) to develop guidelines for the funding and development of embryonic stem cell research. The guidelines give the government authority to begin funding research on embryonic stems developed from surplus cells donated by couples during in... Read More